Microdermics is a Canadian startup founded in 2014, specializing in unlocking continuous biochemical data for clinically relevant insights in the Health Care, Life Sciences, Medical Devices, and Pharmaceutical industries. The company received a $1.00M seed round investment on 21 April 2017 from investors including entrepreneurship@UBC, K5 Ventures, Shoreline Venture Management, and E-Fund. For further information, visit www.microdermics.com.
General Information
BounceWatch is an independent company data service, not affiliated with Microdermics. To contact Microdermics, visit microdermics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Canada Market
Health Care
About Microdermics
Taxonomy: medical device, biopharmaceutical, microneedle technology, drug delivery, biosimilars, innovative delivery system, product lifecycle extensions, needle phobia, healthcare practitioners, biomedical research, biochemical data, needle stick prevention, University of British Columbia research, Vancouver-based company
Funding Rounds & Investors (3)
View AllMicrodermics Alternatives & Competitors
View All AlternativesPioneering the future of anti-aging with innovative needle-free transdermal drug delivery technology...
Delivering future therapeutics within your grasp.
Since 1906 our mission is innovating Cure & Care to make patients’ lives better.
FAQ About Microdermics
Source: BounceWatch company record for Microdermics, https://bouncewatch.com/company/microdermics, updated 20 December 2024. When citing, please name BounceWatch and link this page.